{"id":647797,"date":"2017-05-21T04:04:57","date_gmt":"2017-05-21T04:04:57","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/"},"modified":"2017-05-21T04:04:57","modified_gmt":"2017-05-21T04:04:57","slug":"gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/","title":{"rendered":"Gilead looking to produce new hep C treatment in Egypt -Kabil"},"content":{"rendered":"

<\/a> Pharma producer Gilead Sciences is looking to produce a new hepatitis C treatment <\/strong>in Egypt<\/strong> jointly with a local manufacturer, Trade and Industry Minister Tarek Kabil says. According to Al Masry Al Youm<\/a>, Kabil says Gilead wants to use Egypt as a gateway market to African nations. The medication still awaits FDA approval, he added; Gilead Senior Director Graeme Robertson says the proposed treatment is administered for two months and has a 98% success rate. Robertson added that Egypt is the only country in Africa that has the required infrastructure to produce the treatment.<\/p>\n","protected":false},"excerpt":{"rendered":"

Pharma producer Gilead Sciences is looking to produce a new hepatitis C treatment in Egypt jointly with a local manufacturer, Trade and Industry Minister Tarek Kabil says. According to Al Masry Al Youm, Kabil says Gilead wants to use Egypt as a gateway market to African nations. The medication still awaits FDA approval, he added; […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-647797","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"9ec4e392-c3bc-4b35-84a3-36b87f140a6a","order":"0","is_powered_by":true,"section_story_id":"ccc3705a-82e8-447b-b7cc-1234376e042f","story_type":"1","photo_url":"","photo_position":"above","related_issue":[647785],"teaser":"","voice_url":""},"yoast_head":"\nGilead looking to produce new hep C treatment in Egypt -Kabil - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead looking to produce new hep C treatment in Egypt -Kabil\" \/>\n<meta property=\"og:description\" content=\"Pharma producer Gilead Sciences is looking to produce a new hepatitis C treatment in Egypt jointly with a local manufacturer, Trade and Industry Minister Tarek Kabil says. According to Al Masry Al Youm, Kabil says Gilead wants to use Egypt as a gateway market to African nations. The medication still awaits FDA approval, he added; […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-21T04:04:57+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Gilead looking to produce new hep C treatment in Egypt -Kabil\",\"datePublished\":\"2017-05-21T04:04:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/\"},\"wordCount\":104,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"EnterpriseAM\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/\",\"name\":\"Gilead looking to produce new hep C treatment in Egypt -Kabil - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2017-05-21T04:04:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead looking to produce new hep C treatment in Egypt -Kabil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gilead looking to produce new hep C treatment in Egypt -Kabil - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/","og_locale":"en_US","og_type":"article","og_title":"Gilead looking to produce new hep C treatment in Egypt -Kabil","og_description":"Pharma producer Gilead Sciences is looking to produce a new hepatitis C treatment in Egypt jointly with a local manufacturer, Trade and Industry Minister Tarek Kabil says. According to Al Masry Al Youm, Kabil says Gilead wants to use Egypt as a gateway market to African nations. The medication still awaits FDA approval, he added; […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2017-05-21T04:04:57+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Gilead looking to produce new hep C treatment in Egypt -Kabil","datePublished":"2017-05-21T04:04:57+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/"},"wordCount":104,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["EnterpriseAM","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/","url":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/","name":"Gilead looking to produce new hep C treatment in Egypt -Kabil - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2017-05-21T04:04:57+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/05\/21\/gilead-looking-to-produce-new-hep-c-treatment-in-egypt-kabil\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Gilead looking to produce new hep C treatment in Egypt -Kabil"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":643065,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/29\/gilead-looks-to-acquire-kite-pharma-for-usd-11-9-bn\/","url_meta":{"origin":647797,"position":0},"title":"Gilead looks to acquire Kite Pharma for USD 11.9 bn","author":"enterpriseam admin","date":"29 August 2017","format":false,"excerpt":"M&A WATCH- US pharma company Gilead reached an agreement to acquire Kite for USD 11.9 bn, according to the Financial Times. Gilead \u2014 the maker of hepatitis C cure Sovaldi \u2014 is looking to get its hands on an experimental med which fights cancer by re-engineering the patient\u2019s white blood\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":600998,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/02\/17\/eva-pharma-becomes-licensed-distributor-for-gilead-in-africa-as-egypt-becomes-expansion-hub\/","url_meta":{"origin":647797,"position":1},"title":"Eva Pharma becomes licensed distributor for Gilead in Africa as Egypt becomes expansion hub","author":"enterpriseam admin","date":"17 February 2019","format":false,"excerpt":"Gilead and EvaPharma will use Egypt as a distribution and manufacturing hub to expand into Africa: Eva Pharma will become a licensed distributor for biotech and pharma giant Gilead Sciences\u2019 products in Africa, CEO Riad Armanious said in a statement to the local press on Thursday. Armanious said Gilead has\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":641018,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/11\/egypt-turning-into-global-destination-for-hepatitis-c-treatment\/","url_meta":{"origin":647797,"position":2},"title":"Egypt turning into global destination for Hepatitis C treatment","author":"enterpriseam admin","date":"11 September 2017","format":false,"excerpt":"International outlets are interested in Egypt turning into a global affordable destination for those seeking Hepatitis C treatment. Egypt has been producing the treatment Sovaldi since 2015 since 2015 under a government-sponsored initiative that has lowered the price of a full course of treatment to around USD 83 from around\u2026","rel":"","context":"In "EGYPT IN THE NEWS"","block_context":{"text":"EGYPT IN THE NEWS","link":"https:\/\/enterpriseam.com\/egypt\/category\/egypt-in-the-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":602648,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/04\/02\/gilead-and-evapharma-to-introduce-new-hepatitis-c-drug-to-egypt-in-may\/","url_meta":{"origin":647797,"position":3},"title":"Gilead and EvaPharma to introduce new Hepatitis C drug to Egypt in May","author":"enterpriseam admin","date":"2 April 2019","format":false,"excerpt":"US pharma company Gilead International aims to introduce Vosevi, a Hepatitis C drug, to Egypt within the next two months, said Amgad Talaat, general manager of EvaPharma, Gilead\u2019s agent in Africa. Talaat said the drug, which will target patients who have not responded to available treatments such as Sovaldi, is\u2026","rel":"","context":"In "Health + Education"","block_context":{"text":"Health + Education","link":"https:\/\/enterpriseam.com\/egypt\/category\/health-education\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":652951,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/01\/23\/egypts-hepatitis-c-treatment-program-could-be-a-model-globally\/","url_meta":{"origin":647797,"position":4},"title":"Egypt\u2019s hepatitis C treatment program could be a model globally","author":"enterpriseam admin","date":"23 January 2017","format":false,"excerpt":"Egypt\u2019s program to treat hepatitis C patients using medications including Sovaldi has treated nearly one mn patients, most at the government\u2019s expense, and now experts say it could be a model for the rest of the world, Heba Saleh writes in The Financial Times. \u201cGilead agreed to provide the medicine\u2026","rel":"","context":"In "EGYPT IN THE NEWS"","block_context":{"text":"EGYPT IN THE NEWS","link":"https:\/\/enterpriseam.com\/egypt\/category\/egypt-in-the-news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":636948,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/11\/05\/french-development-agency-to-give-egypt-eur-31-mn-for-healthcare-development\/","url_meta":{"origin":647797,"position":5},"title":"French Development Agency to give Egypt EUR 31 mn for healthcare development:","author":"enterpriseam admin","date":"5 November 2017","format":false,"excerpt":"French Development Agency to give Egypt EUR 31 mn for healthcare development: The Health Ministry signed an MoU with the French Development Agency that will see the latter fund the development of 709 medical facilities ahead of the implementation of the Universal Healthcare Act, Minister Ahmed Rady said on Thursday,\u2026","rel":"","context":"In "Diplomacy + Foreign Trade"","block_context":{"text":"Diplomacy + Foreign Trade","link":"https:\/\/enterpriseam.com\/egypt\/category\/diplomacy-foreign-trade\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/647797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=647797"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/647797\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/647785"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=647797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=647797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=647797"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=647797"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=647797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}